Kalça kırığı cerrahisi geçiren yaşlı hastalarda uzun dönem antitrombotik tedavilerin perioperatif morbidite ve mortalite üzerine etkisi

ABSTRACT
 Objective: Ischemic complications or massive bleeding are important perioperative in elderly patients using antithrombotic drugs. The need for blood product replacement, transfusion-related complications, prolonged stay hospital and intensive care unit, high mortality the period can be seen. aim of this study was to investigate effects long-term different therapies on morbidity undergoing surgery hip fracture.
 Materials Methods: This retrospective cohort included aged 65 years older who underwent fracture between 2015 2018. Patients with no treatment (Group NonAT), warfarin Warfarin), novel oral anticoagulants NOACs), dual antiplatelet therapy DAPT) were compared terms major bleeding, deep venous thrombosis (DVT) pulmonary thromboembolism (PTE) length (LOS), ICU admission, 30-day mortality.
 Results: 668 patients; demographic data Group NonAT (n=442), Warfarin (n=59), NOACs (n=30) DAPT(n=137) similar. Major red cell transfusion did not differ statistically all groups. (p>0.05) preoperative postoperative Hb values groups (p>0.05). Mortality, only there significantly higher group than non user group. (p0.05) However survival significant (p